An article discusses the rise of biotech stocks in 2025, focusing on Vigil Neuroscience, Inc. and its advancements in treating neurodegenerative diseases. The company's positive clinical trial data has led to a surge in stock value.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay